Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
231M
-
Shares change
-
+2.87M
-
Total reported value, excl. options
-
$2.21B
-
Value change
-
+$14.1M
-
Put/Call ratio
-
0.25
-
Number of buys
-
86
-
Number of sells
-
-91
-
Price
-
$9.58
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2018
233 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q4 2018.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 231M shares
of 309M outstanding shares and own 74.85% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (20.7M shares), FMR LLC (17.9M shares), Vanguard Group Inc (17.2M shares), BlackRock Inc. (16.5M shares), JANUS HENDERSON GROUP PLC (11.1M shares), venBio Select Advisor LLC (10.1M shares), JENNISON ASSOCIATES LLC (9.82M shares), STATE STREET CORP (8.55M shares), Redmile Group, LLC (8.32M shares), and WELLINGTON MANAGEMENT GROUP LLP (7.57M shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.